1. Home
  2. BDTX vs FITBO Comparison

BDTX vs FITBO Comparison

Compare BDTX & FITBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • FITBO
  • Stock Information
  • Founded
  • BDTX 2014
  • FITBO N/A
  • Country
  • BDTX United States
  • FITBO United States
  • Employees
  • BDTX N/A
  • FITBO 18607
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • FITBO Major Banks
  • Sector
  • BDTX Health Care
  • FITBO Finance
  • Exchange
  • BDTX Nasdaq
  • FITBO Nasdaq
  • Market Cap
  • BDTX 132.5M
  • FITBO N/A
  • IPO Year
  • BDTX 2020
  • FITBO N/A
  • Fundamental
  • Price
  • BDTX $2.95
  • FITBO $19.83
  • Analyst Decision
  • BDTX Strong Buy
  • FITBO
  • Analyst Count
  • BDTX 6
  • FITBO 0
  • Target Price
  • BDTX $14.83
  • FITBO N/A
  • AVG Volume (30 Days)
  • BDTX 1.2M
  • FITBO N/A
  • Earning Date
  • BDTX 08-05-2025
  • FITBO N/A
  • Dividend Yield
  • BDTX N/A
  • FITBO N/A
  • EPS Growth
  • BDTX N/A
  • FITBO N/A
  • EPS
  • BDTX 0.09
  • FITBO N/A
  • Revenue
  • BDTX $70,000,000.00
  • FITBO N/A
  • Revenue This Year
  • BDTX N/A
  • FITBO N/A
  • Revenue Next Year
  • BDTX N/A
  • FITBO N/A
  • P/E Ratio
  • BDTX $33.54
  • FITBO N/A
  • Revenue Growth
  • BDTX N/A
  • FITBO N/A
  • 52 Week Low
  • BDTX $1.20
  • FITBO N/A
  • 52 Week High
  • BDTX $6.75
  • FITBO N/A
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 71.02
  • FITBO 42.02
  • Support Level
  • BDTX $2.43
  • FITBO $19.81
  • Resistance Level
  • BDTX $2.72
  • FITBO $20.43
  • Average True Range (ATR)
  • BDTX 0.17
  • FITBO 0.23
  • MACD
  • BDTX 0.03
  • FITBO 0.05
  • Stochastic Oscillator
  • BDTX 93.85
  • FITBO 23.08

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About FITBO Fifth Third Bancorp Depositary Shares each representing a 1/1000th ownership interest in a share of Non-Cumulative Perpetual Preferred Stock Series K

Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $200 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.

Share on Social Networks: